Kindstar Globalgene Technology, Inc. (Kindstar Global) disclosed a minor share repurchase conducted on 08 October 2026, acquiring 24,000 ordinary shares on the Hong Kong Stock Exchange.

The buyback was executed within a price range of HKD 0.92–0.95 per share, resulting in a volume-weighted average cost of approximately HKD 0.94 and a total cash outlay of HKD 22.64 thousand. All repurchased shares will be held as treasury shares; no cancellations were undertaken.

Following the transaction: • Issued shares (excluding treasury shares) declined by 24,000 to 1.03179 billion, a reduction of 0.00233%. • Treasury shares increased to 9.54 million. • Total issued share capital remains unchanged at 1.04133 billion shares.

The repurchase forms part of the mandate approved on 05 June 2026, which authorises buybacks of up to 103.43 million shares. To date, Kindstar Global has repurchased 2.47 million shares under this mandate, representing 0.24% of the company’s issued share base at the mandate date. Under Hong Kong listing rules, the company is restricted from issuing new shares or disposing of treasury shares until 07 November 2026.